Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Celiac disease associated SNP rs17810546 is located in a gene silencing region.

Zwiers A, van Wanrooij RLJ, Dieckman T, Nijeboer P, Kraal G, Bouma G.

Gene. 2019 Nov 11:144165. doi: 10.1016/j.gene.2019.144165. [Epub ahead of print]

PMID:
31726085
2.

Rapid Response to Treatment of Autoimmune Hepatitis Associated with Remission at 6 and 12 Months.

Pape S, Gevers TJG, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Taubert R, Jaeckel E, Manns MP, Papp M, Sipeki N, Stickel F, Efe C, Ozaslan E, Purnak T, Nevens F, Kessener DJN, Kahraman A, Wedemeyer H, Hartl J, Schramm C, Lohse AW, Drenth JPH, Heneghan MA.

Clin Gastroenterol Hepatol. 2019 Nov 9. pii: S1542-3565(19)31268-6. doi: 10.1016/j.cgh.2019.11.013. [Epub ahead of print]

PMID:
31715274
3.

Adverse events related to low dose corticosteroids in autoimmune hepatitis.

van den Brand FF, van der Veen KS, Lissenberg-Witte BI, de Boer YS, van Hoek B, Drenth JPH, Verdonk RC, Vrolijk JM, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study Group.

Aliment Pharmacol Ther. 2019 Nov;50(10):1120-1126. doi: 10.1111/apt.15528. Epub 2019 Oct 15.

PMID:
31617229
4.

Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L, Collin P, Green PHR, Crowe SE, Tsuji W, Butz E, Cerf-Bensussan N, Macintyre E, Parnes JR, Leon F, Hermine O, Mulder CJ; RCD-II Study Group Investigators.

Lancet Gastroenterol Hepatol. 2019 Dec;4(12):960-970. doi: 10.1016/S2468-1253(19)30265-1. Epub 2019 Sep 4.

PMID:
31494097
5.

Faecal Scent as a Novel Non-Invasive Biomarker to Discriminate between Coeliac Disease and Refractory Coeliac Disease: A Proof of Principle Study.

Rouvroye MD, Wicaksono A, Bosch S, Savelkoul E, Covington JA, Beaumont H, Mulder CJ, Bouma G, de Meij TGJ, de Boer NKH.

Biosensors (Basel). 2019 May 27;9(2). pii: E69. doi: 10.3390/bios9020069.

6.

Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis.

Pape S, Gevers TJG, Belias M, Mustafajev IF, Vrolijk JM, van Hoek B, Bouma G, van Nieuwkerk CMJ, Hartl J, Schramm C, Lohse AW, Taubert R, Jaeckel E, Manns MP, Papp M, Stickel F, Heneghan MA, Drenth JPH.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2068-2075.e2. doi: 10.1016/j.cgh.2018.12.035. Epub 2019 Jan 6.

PMID:
30625402
7.

Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma.

van Gils T, Nijeboer P, Overbeek LI, Hauptmann M, Castelijn DA, Bouma G, Mulder CJ, van Leeuwen FE, de Jong D.

United European Gastroenterol J. 2018 Dec;6(10):1485-1495. doi: 10.1177/2050640618800540. Epub 2018 Sep 12.

8.

CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors.

Bar-Ephraim YE, Koning JJ, Burniol Ruiz E, Konijn T, Mourits VP, Lakeman KA, Boon L, Bögels M, van Maanen JP, Den Haan JMM, van Egmond M, Bouma G, Reijmers RM, Mebius RE.

J Immunol. 2019 Jan 1;202(1):171-182. doi: 10.4049/jimmunol.1701153. Epub 2018 Nov 30.

PMID:
30504420
9.

Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis.

de Boer YS, Gerussi A, van den Brand FF, Wong GW, Halliday N, Liberal R, Drenth JPH, Thorburn D, Bouma G; Dutch Autoimmune Hepatitis Study Group, Heneghan MA.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1616-1624.e2. doi: 10.1016/j.cgh.2018.11.028. Epub 2018 Nov 22.

PMID:
30471454
10.

Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis.

van den Brand FF, van der Veen KS, de Boer YS, van Gerven NM, Lissenberg-Witte BI, Beuers U, van Erpecum KJ, van Buuren HR, den Ouden JW, Brouwer JT, Vrolijk JM, Verdonk RC, van Hoek B, Koek GH, Drenth JPH, Guichelaar MMJ, Mulder CJJ, Bloemena E, van Nieuwkerk CMJ, Bouma G; Dutch Autoimmune Hepatitis Study Group.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):940-947.e2. doi: 10.1016/j.cgh.2018.09.046. Epub 2018 Oct 3.

PMID:
30291909
11.

The daily practice of (suspected) coeliac disease management by general practitioners: A qualitative approach.

van Gils T, Senler TG, van der Horst HE, Mulder CJJ, Bouma G, de Vries H.

Eur J Gen Pract. 2018 Dec;24(1):236-242. doi: 10.1080/13814788.2018.1516203.

12.

Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.

Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, Fernández-Bañares F, Kupcinskas J, Munck LK, Rehbehn KU, Nacak T, Greinwald R, Münch A; BUG-1/LMC Study Group.

Gastroenterology. 2018 Dec;155(6):1795-1804.e3. doi: 10.1053/j.gastro.2018.08.042. Epub 2018 Sep 7.

13.

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands.

van den Brand FF, van Nieuwkerk CMJ, Verwer BJ, de Boer YS, de Boer NKH, Mulder CJJ, Bloemena E, Bakker CM, Vrolijk JM, Drenth JPH, Tan ACITL, Ter Borg F, Ter Borg MJ, van den Hazel SJ, Inderson A, Tushuizen ME, Bouma G.

Aliment Pharmacol Ther. 2018 Oct;48(7):761-767. doi: 10.1111/apt.14939. Epub 2018 Aug 15.

14.

Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.

Baven-Pronk MAMC, Biewenga M, van Silfhout JJ, van den Berg AP, van Buuren HR, Verwer BJ, van Nieuwkerk CMJ, Bouma G, van Hoek B.

Clin Transl Gastroenterol. 2018 Jul 2;9(6):165. doi: 10.1038/s41424-018-0028-1.

15.

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes.

Momozawa Y, Dmitrieva J, Théâtre E, Deffontaine V, Rahmouni S, Charloteaux B, Crins F, Docampo E, Elansary M, Gori AS, Lecut C, Mariman R, Mni M, Oury C, Altukhov I, Alexeev D, Aulchenko Y, Amininejad L, Bouma G, Hoentjen F, Löwenberg M, Oldenburg B, Pierik MJ, Vander Meulen-de Jong AE, Janneke van der Woude C, Visschedijk MC; International IBD Genetics Consortium, Lathrop M, Hugot JP, Weersma RK, De Vos M, Franchimont D, Vermeire S, Kubo M, Louis E, Georges M.

Nat Commun. 2018 Jun 21;9(1):2427. doi: 10.1038/s41467-018-04365-8.

16.

A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.

Hrdlickova B, Mulder CJ, Malamut G, Meresse B, Platteel M, Kamatani Y, Ricaño-Ponce I, van Wanrooij RLJ, Zorro MM, Jan Bonder M, Gutierrez-Achury J, Cellier C, Zhernakova A, Nijeboer P, Galan P, Withoff S, Lathrop M, Bouma G, Xavier RJ, Jabri B, Bensussan NC, Wijmenga C, Kumar V.

Eur J Gastroenterol Hepatol. 2018 Aug;30(8):828-837. doi: 10.1097/MEG.0000000000001168.

17.

Gamma-Delta T Lymphocytes in the Diagnostic Approach of Coeliac Disease.

Nijeboer P, van Gils T, Reijm M, Ooijevaar R, Lissenberg-Witte BI, Bontkes HJ, Mulder CJJ, Bouma G.

J Clin Gastroenterol. 2019 May/Jun;53(5):e208-e213. doi: 10.1097/MCG.0000000000001060.

PMID:
29782465
18.

Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.

Simsek M, Meijer B, Ramsoekh D, Bouma G, van der Wouden EJ, den Hartog B, de Vries AC, Hoentjen F, Dijkstra G, de Boer SY, Jansen JM, van der Meulen AE, Beukers R, Brink MA, Steinhauser T, Oldenburg B, Gilissen LP, Naber TH, Verhagen MA, de Boer NKH, Mulder CJJ; Dutch Initiative on Crohn and Colitis (ICC).

Clin Gastroenterol Hepatol. 2019 Feb;17(3):568-570. doi: 10.1016/j.cgh.2018.05.009. Epub 2018 Jun 1.

PMID:
29775790
19.

Salivary Function and Oral Health Problems in Crohn's Disease Patients.

de Vries SAG, Tan CXW, Bouma G, Forouzanfar T, Brand HS, de Boer NK.

Inflamm Bowel Dis. 2018 May 18;24(6):1361-1367. doi: 10.1093/ibd/izy017.

PMID:
29718221
20.

Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies.

Severs M, Spekhorst LM, Mangen MJ, Dijkstra G, Löwenberg M, Hoentjen F, van der Meulen-de Jong AE, Pierik M, Ponsioen CY, Bouma G, van der Woude JC, van der Valk ME, Romberg-Camps MJL, Clemens CHM, van de Meeberg P, Mahmmod N, Jansen J, Jharap B, Weersma RK, Oldenburg B, Festen EAM, Fidder HH.

Inflamm Bowel Dis. 2018 May 18;24(6):1298-1306. doi: 10.1093/ibd/izy004.

PMID:
29688413

Supplemental Content

Loading ...
Support Center